Nisoxetine 尼索西汀,98.28%

产品编号:Bellancom-B1704| CAS NO:53179-07-0| 分子式:C17H21NO2| 分子量:271.35

尼西西汀是去甲肾上腺素转运体(NET)的有效选择性抑制剂,Kd为0.76nM。尼西西汀是一种抗抑郁药和局部麻醉剂,它可以阻断电压门控钠通道。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-B1704
950.00 杭州 北京(现货)
Bellancom-B1704
1500.00 杭州 北京(现货)
Bellancom-B1704
3000.00 杭州 北京(现货)
Bellancom-B1704
4900.00 杭州 北京(现货)
Bellancom-B1704
7850.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Nisoxetine 尼索西汀

产品介绍 Nisoxetine 是一种有效的和选择性的去甲肾上腺素转运蛋白 (NET) 抑制剂,Kd 值为 0.76 nM。Nisoxetine 是一种抗抑郁试剂和局部麻药,它可以阻断电压门控性钠通道
生物活性

Nisoxetine is a potent and selective inhibitor of noradrenaline transporter (NET), with a Kd of 0.76 nM. Nisoxetine is an antidepressant and local anesthetic, it can block voltage-gated sodium channels.

体外研究

Nisoxetine 抑制 [3H]Nisoxetine 与大鼠额叶皮层膜的结合,Ki 为 1.4±0.1 nM
Nisoxetine 抑制[3H]去甲肾上腺素摄取到大鼠额叶皮质突触体中,Ki 为 2.1±0.3 nM
Nisoxetine 抑制 Na+ 电流,膜电位为 -70 和 -100 mV 时的 IC50 分别为 1.6 和 28.6 µM

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Nisoxetine (2.2 µM; a single intrathecal injection) shows 100, 100, and 100% of blockades in motor function, proprioception, and with duration of action of about 61, 96, and 236 min, respectively.
Nisoxetine (3,10, 30 mg/kg, i.p.) inhibits refeeding response (intake of standard chow) in rats[4].

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley rats(290-340 g)
Dosage: 0.6, 1.2, 1.8, 2.2 µM
Administration: A single intrathecal injection
Result: Showed ED50s of 0.82, 0.75 and 0.70 µM in blocking motor function, proprioception, and nociception respectively.
体内研究

Nisoxetine (2.2 µM; a single intrathecal injection) shows 100, 100, and 100% of blockades in motor function, proprioception, and with duration of action of about 61, 96, and 236 min, respectively.
Nisoxetine (3,10, 30 mg/kg, i.p.) inhibits refeeding response (intake of standard chow) in rats[4].

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley rats(290-340 g)
Dosage: 0.6, 1.2, 1.8, 2.2 µM
Administration: A single intrathecal injection
Result: Showed ED50s of 0.82, 0.75 and 0.70 µM in blocking motor function, proprioception, and nociception respectively.
性状Viscous liquid
溶解性数据
In Vitro: 

DMSO : 250 mg/mL (921.32 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.6853 mL 18.4264 mL 36.8528 mL
5 mM 0.7371 mL 3.6853 mL 7.3706 mL
10 mM 0.3685 mL 1.8426 mL 3.6853 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Pure form -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


海关编码 2922299090

~%

53179-07-0结构式

53179-07-0

文献:Andersen, Jacob; Stuhr-Hansen, Nicolai; Zachariassen, Linda Gronborg; Koldso, Heidi; Schiott, Birgit; Stromgaard, Kristian; Kristensen, Anders S. Molecular Pharmacology, 2014 , vol. 85, # 5 p. 703 - 714

~%

53179-07-0结构式

53179-07-0

文献:Andersen, Jacob; Stuhr-Hansen, Nicolai; Zachariassen, Linda Gronborg; Koldso, Heidi; Schiott, Birgit; Stromgaard, Kristian; Kristensen, Anders S. Molecular Pharmacology, 2014 , vol. 85, # 5 p. 703 - 714

服务热线

13911702513
18601927057

微信客服